1. CDC Vital Signs: Current cigarette smoking among adults aged ≥18 years—United States, 2005–2010. Accessed 12/10/2012. www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm .
2. Krupski, W. C., Olive, G. C., Weber, C. A., & Rapp, J. H. (1987). Comparative effects of hypertension and nicotine on injury induced myointimal thickening. Surgery, 102, 409–415.
3. Benowitz, N. L., Hansson, A., & Jacob, P., I. I. I. (2002). Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension, 39, 1107–1112.
4. Fishebein, L., O’Brien, P., Hutson, A., Theriaque, D., Stacpoole, P. W., & Flotte, T. (2000). Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. Journal of Investigative Medicine, 48, 435–440.
5. Martins, L. C., Ferreira-Melo, S. E., Sabha, M., Coelho, O. R., Yugar-Toledo, J. C., Quinaglia, T., et al. (2009). Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers. Blood Pressure, 18(4), 255–260.